Sutro Biopharma Inc

NASDAQ:STRO   1:22:09 PM EDT
18.86
-0.44 (-2.28%)
Products

Sutro Biopharma Gets FDA Fast Track Designation For Ovarian Cancer Trial Drug

Published: 08/18/2021 11:21 GMT
Sutro Biopharma Inc (STRO) - Sutro Biopharma Announces Stro-002 FDA Fast Track Designation for Patients With Advanced Ovarian Cancer.